NeuroPhage
Pharmaceuticals develops disaggregating misfolded proteins for the treatment and prevention of chronic neurodegenerative diseases... Read moreNeuroPhage
Pharmaceuticals develops disaggregating misfolded proteins for the treatment and prevention of chronic neurodegenerative diseases... Read more
News
Jul 20, 2015
BIOSPACE
NeuroPhage: NeuroPhage Pharmaceuticals, Inc.'s NPT088 Universally Targets Misfolded Proteins In Preclinical Studies Highlighted In Oral Session At The
Jul 19, 2015
PR NEWSWIRE
Press Release: NeuroPhage : NeuroPhage's NPT088 Universally Targets Misfolded Proteins in Preclinical Studies Highlighted in Oral Session at the Alzheimer's Association International Conference
Jul 13, 2015
SYS-CON MEDIA
NeuroPhage: NeuroPhage to be Featured in Oral Session at the 2015 Alzheimer's Association International Conference
Jul 13, 2015
PR NEWSWIRE
Press Release: NeuroPhage : NeuroPhage to be Featured in Oral Session at the 2015 Alzheimer's Association International Conference
Mar 20, 2015
BIOSPACE
NeuroPhage: NeuroPhage Pharmaceuticals, Inc. To Participate On Neuroscience Drug Development Panel At March 27, 2015
Mar 20, 2015
PR NEWSWIRE
Press Release: NeuroPhage : NeuroPhage to Participate on Neuroscience Drug Development Panel at MassBio Annual Meeting March 27, 2015
Mar 17, 2015
BIOSPACE
NeuroPhage: NeuroPhage Pharmaceuticals, Inc. To Present At
Mar 17, 2015
PR NEWSWIRE
Press Release: NeuroPhage : NeuroPhage to Present at 12th International Conference on Alzheimer's & Parkinson's Diseases
Jan 16, 2015
MEDCITY NEWS
NeuroPhage: NeuroPhage adds $10M to its Series D to bring its brain plaque-clearing Alzheimer's drug to clinic
Jan 14, 2015
FINSMEs
NeuroPhage: NeuroPhage Pharmaceuticals Raises $10.0M in Series D Financing
NeuroPhage Competitors
1
2
3
4
5
6
7
8
9
10